1
|
Savoie Iii FH, Delvadia BP, Tate JP, Winter JE, Williams GH, Sherman WF, O'Brien MJ. Biologics in rotator cuff repair. Bone Joint J 2024; 106-B:978-985. [PMID: 39216849 DOI: 10.1302/0301-620x.106b9.bjj-2024-0513.r1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 09/04/2024]
Abstract
Rotator cuff tears are common in middle-aged and elderly patients. Despite advances in the surgical repair of rotator cuff tears, the rates of recurrent tear remain high. This may be due to the complexity of the tendons of the rotator cuff, which contributes to an inherently hostile healing environment. During the past 20 years, there has been an increased interest in the use of biologics to complement the healing environment in the shoulder, in order to improve rotator cuff healing and reduce the rate of recurrent tears. The aim of this review is to provide a summary of the current evidence for the use of forms of biological augmentation when repairing rotator cuff tears.
Collapse
Affiliation(s)
- Felix H Savoie Iii
- Department of Orthopaedic Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA
- Tulane Doctors-Sports Medicine Plus, University Medical Center New Orleans, Lakeside Hospital, Omega Hospital Surgery Center, East Jefferson Hospital, and Slidell Memorial Hospital, Slidell, Louisiana, USA
| | - Bela P Delvadia
- Department of Orthopaedic Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA
- Tulane Doctors-Sports Medicine Plus, University Medical Center New Orleans, Lakeside Hospital, Omega Hospital Surgery Center, East Jefferson Hospital, and Slidell Memorial Hospital, Slidell, Louisiana, USA
| | - Jackson P Tate
- Department of Orthopaedic Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA
- Tulane Doctors-Sports Medicine Plus, University Medical Center New Orleans, Lakeside Hospital, Omega Hospital Surgery Center, East Jefferson Hospital, and Slidell Memorial Hospital, Slidell, Louisiana, USA
| | - Julianna E Winter
- Department of Orthopaedic Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA
- Tulane Doctors-Sports Medicine Plus, University Medical Center New Orleans, Lakeside Hospital, Omega Hospital Surgery Center, East Jefferson Hospital, and Slidell Memorial Hospital, Slidell, Louisiana, USA
| | - Garrett H Williams
- Department of Orthopaedic Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA
- Tulane Doctors-Sports Medicine Plus, University Medical Center New Orleans, Lakeside Hospital, Omega Hospital Surgery Center, East Jefferson Hospital, and Slidell Memorial Hospital, Slidell, Louisiana, USA
| | - William F Sherman
- Department of Orthopaedic Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA
- Tulane Doctors-Sports Medicine Plus, University Medical Center New Orleans, Lakeside Hospital, Omega Hospital Surgery Center, East Jefferson Hospital, and Slidell Memorial Hospital, Slidell, Louisiana, USA
| | - Michael J O'Brien
- Department of Orthopaedic Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA
- Tulane Doctors-Sports Medicine Plus, University Medical Center New Orleans, Lakeside Hospital, Omega Hospital Surgery Center, East Jefferson Hospital, and Slidell Memorial Hospital, Slidell, Louisiana, USA
| |
Collapse
|
2
|
Sewpaul Y, Huynh RCT, Hartland AW, Leung B, Teoh KH, Rashid MS. Non-steroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors Do Not Affect Healing After Rotator Cuff Repair: A Systematic Review and Meta-analysis. Arthroscopy 2024; 40:930-940.e1. [PMID: 37967731 DOI: 10.1016/j.arthro.2023.10.048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/20/2023] [Revised: 10/20/2023] [Accepted: 10/25/2023] [Indexed: 11/17/2023]
Abstract
PURPOSE To determine whether non-steroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 (COX-2) inhibitors affect healing rate, functional outcomes, and patient satisfaction after rotator cuff repair. METHODS Medline, EMBASE, PsychINFO and the Cochrane Library were searched for randomized controlled trials (RCTs) investigating the use of NSAIDs and COX-2 inhibitors after arthroscopic rotator cuff repair. Primary outcomes included healing and retear rate, determined by radiological imaging. Secondary outcomes included shoulder-specific outcome measures and the visual analog scale (VAS). Risk of bias was graded using the Cochrane risk-of-bias v2.0 tool. The GRADE framework was used to assess certainty of findings. RESULTS Seven RCTs with a total of 507 patients were included (298 randomized to NSAID/COX-2 vs 209 randomized to control). NSAIDs use did not yield a difference in retear rate (P = .77). NSAIDs were shown to significantly reduce pain in the perioperative period (P = .01); however, no significant difference was present at a minimum of 6 months (P = .11). COX-2 inhibitors did not significantly reduce pain (P = .15). Quantitative analysis of ASES and UCLA scores showed NSAIDs significantly improved functional outcomes versus control (P = .004). COX-2 inhibitors did not significantly improve functional outcomes (P = .15). Two trials were deemed "low" risk of bias, four trials were graded to have "some concerns", and one trial was graded to have "high" risk of bias. Retear rate and functional PROMs were deemed to have "low" certainty. VAS pain scale was graded to have "moderate" certainty. CONCLUSIONS This systematic review and meta-analysis indicates that NSAIDs do not affect healing rate after arthroscopic rotator cuff repair, but they do significantly improve postoperative pain and functional outcomes. No significant difference was seen in pain or functional outcomes with the use of COX-2 inhibitors. LEVEL OF EVIDENCE Level I, meta-analysis of randomized controlled trials.
Collapse
Affiliation(s)
- Yash Sewpaul
- Lancaster Medical School, Lancaster University, Lancaster, United Kingdom
| | | | | | - Brook Leung
- Royal London Hospital, Whitechapel, London, United Kingdom
| | - Kar Hao Teoh
- Department of Trauma and Orthopaedic Surgery, Princess Alexandra Hospital, Harlow, United Kingdom
| | - Mustafa S Rashid
- Manchester University NHS Foundation Trust, Manchester, United Kingdom.
| |
Collapse
|
3
|
Yeo MHX, Seah SJS, Lee M, Lie DTT. Different types of rotator cuff tear morphology do not affect post-repair clinical outcomes in large to massive tears. J ISAKOS 2024; 9:25-33. [PMID: 37925105 DOI: 10.1016/j.jisako.2023.10.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2023] [Revised: 10/28/2023] [Accepted: 10/30/2023] [Indexed: 11/06/2023]
Abstract
OBJECTIVES The primary aim of this current study is to evaluate the effects of rotator cuff tear morphology on clinical outcomes in large to massive tears, using a modified version of the existing classification system, with specific focus on tear symmetry and use of margin convergence. METHODS Patients who underwent arthroscopic repair of large to massive, full thickness rotator cuff tears were retrospectively analysed. The tear pattern was classified at the time of surgery as Type IA, Type IB, Type IIA, and Type IIB according to tear symmetry and direction of maximum tear diameter, with Type I being symmetrical and Type II being asymmetrical. Type IA (U-shaped) had greater mediolateral (ML) than anteroposterior (AP) diameter while Type IB (crescent shaped) had greater AP than ML diameter. Type IIA tears have an anterior extension towards the rotator interval while IIB tears have a posterior extension into the infraspinatus, similar to AP L-shaped tears established in the literature. Type I tears were typically repaired from medial to lateral while Type II tears were repaired diagonally. All types were repaired using double row technique, with the addition of margin convergence for Types IA and IIB, which had larger tears in the medial and lateral directions. Primary outcome measures were Oxford Shoulder Score, Constant Shoulder Score, University of California at Los Angeles Shoulder Score followed-up at 6, 12, and 24-months as well as retear rates at latest follow-up. RESULTS In total, 109 patients were included in the study with a mean age of 65.5 ± 9.4. The prevalence of each tear morphologies from Type IA to IIB was 22.0 %, 34.9 %, 27.5 %, and 15.6 %, respectively. All four groups showed statistically significant improvement from pre-operative scores in all 3 outcome measures at 24 months (p < 0.001 for all). No significant difference in primary outcome measures or retear rates was detected between all 4 groups. CONCLUSION This study found that different types of cuff tear morphology, despite affecting surgical repair technique, does not influence clinical outcomes post-arthroscopic rotator cuff repair at mid-term follow-up. LEVEL OF EVIDENCE Retrospective Cohort study, Level III.
Collapse
Affiliation(s)
- Mark H X Yeo
- Department of Orthopaedic Surgery, Singapore General Hospital, 1 Outram Road, Singapore, 169608, Singapore
| | - Shawn J S Seah
- Department of Orthopaedic Surgery, Singapore General Hospital, 1 Outram Road, Singapore, 169608, Singapore
| | - Merrill Lee
- Department of Orthopaedic Surgery, Singapore General Hospital, 1 Outram Road, Singapore, 169608, Singapore
| | - Denny Tjiauw Tjoen Lie
- Department of Orthopaedic Surgery, Singapore General Hospital, 1 Outram Road, Singapore, 169608, Singapore.
| |
Collapse
|
4
|
Seah SJS, Yeo MHX, Gatot C, Lie D. Non-selective NSAIDs do not increase retear rates post-arthroscopic rotator cuff repair: A meta-analysis. J ISAKOS 2023; 8:216-226. [PMID: 37085034 DOI: 10.1016/j.jisako.2023.04.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2022] [Revised: 03/31/2023] [Accepted: 04/06/2023] [Indexed: 04/23/2023]
Abstract
BACKGROUND Arthroscopic rotator cuff repairs (RCRs) are known to be associated with substantial pain and post-operative pain management is critical in overall patients' outcomes. Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used oral medications and can reduce opioid usage. However, controversies arise due to its postulated effect on postoperative tendon healing. As the evidence of safety and efficacy of NSAIDs remains unclear, this study aims to investigate the effect of NSAIDs on retear rates and clinical outcomes. METHODS A systematic search of four databases (PubMed, EMBASE, Scopus, and Cochrane Library) was conducted, identifying studies that compared cohorts with post-RCR NSAIDs use versus control groups without NSAID use. Meta-analysis was conducted for retear rate as well as pain and functional outcomes (Visual Analogue Scale and American Shoulder and Elbow Surgeons Shoulder score). Subgroup analysis was conducted for retear rates to determine the overall treatment effect of including selective COX-2 inhibitors. RESULTS Six studies were included in the meta-analysis. The total baseline cohort size was 916, with 443 (48.3%) patients in the NSAID group and 473 (51.6%) patients in the control group. There were no statistically significant differences in the baseline characteristics between the two groups. Meta-analysis between the two groups showed that there were no statistically significant differences in retear rates (p = 0.70), early and late post-operative Visual Analogue Scale score (p = 0.10 and p = 0.10, respectively) and latest American Shoulder and Elbow Surgeons Shoulder score (p = 0.31). However, subgroup analysis of retear rates revealed a statistically significant difference between the subgroup including COX-2 selective inhibitor versus non-selective COX inhibitor (p < 0.01). CONCLUSION NSAID use in post-arthroscopic RCR pain relief does not increase retear rates and can provide similar clinical outcomes compared to a non-NSAID regimen. LEVEL OF EVIDENCE Meta-analysis, level of evidence, 4.
Collapse
Affiliation(s)
- Shawn J S Seah
- Yong Loo Lin School of Medicine, National University of Singapore, 117597, Singapore
| | - Mark H X Yeo
- Yong Loo Lin School of Medicine, National University of Singapore, 117597, Singapore
| | - Cheryl Gatot
- Department of Orthopedic Surgery, Singapore General Hospital, 169608, Singapore
| | - Denny Lie
- Department of Orthopedic Surgery, Singapore General Hospital, 169608, Singapore.
| |
Collapse
|
5
|
Safety and Efficacy of Postoperative Nonsteroidal Anti-inflammatory Drugs in Sports Medicine. J Am Acad Orthop Surg 2022; 30:535-542. [PMID: 35576538 DOI: 10.5435/jaaos-d-21-01228] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/22/2021] [Accepted: 02/25/2022] [Indexed: 02/01/2023] Open
Abstract
Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for multimodal pain control after surgery. These medications work by selective or nonselective inhibition of cyclooxygenase, which has downstream effects on thromboxanes, prostaglandins, and prostacyclins. Clinical studies have shown beneficial effects for alleviating pain and reducing opioid consumption after surgery. Within hip arthroscopy, there is evidence that postoperative NSAIDs can also reduce the risk of symptomatic heterotopic bone formation. However, preclinical and animal studies have raised concern over the effect of NSAIDs on bone and soft-tissue healing. In addition, selective and nonselective cyclooxygenase 2 inhibitors may have different safety profiles regarding postoperative soft-tissue healing. The purpose of this review was to outline the mechanisms of action, efficacy, and effect on soft-tissue healing of postoperative NSAIDs and to provide evidence-based recommendations for appropriate use.
Collapse
|
6
|
Kim HM, Hsu JE, Ricchetti ET. What's New in Shoulder and Elbow Surgery. J Bone Joint Surg Am 2021; 103:1865-1871. [PMID: 34403378 DOI: 10.2106/jbjs.21.00698] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Affiliation(s)
- H Mike Kim
- Department of Orthopaedic Surgery, Missouri Orthopaedic Institute, University of Missouri, Columbia, Missouri
| | - Jason E Hsu
- Department of Orthopaedic Surgery, University of Washington, Seattle, Washington
| | - Eric T Ricchetti
- Department of Orthopaedic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio
| |
Collapse
|